| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Air Liquide Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902. Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. … | 1413 | 1063 | 330 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: | 1865 | 1250 | 257 |
 | Atos Advancing what matters This account discusses mainly (but not exclusively) the activities of Tech Foundations - the Atos Group business line leading in managed services, focusing on hybrid cloud & infrastructure, employee experience and technology services, through decarbonized, automated and AI-enabled solutions. Eviden designs the scope composed of Atos’ digital, cloud, big data and security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation. Visit Eviden: https://www.linkedin.com/company/eviden/ and eviden.com Atos is a global leader in digital transformation with 95,000 employees and annual revenue of c. €11 billion. European number one in cybersecurity, cloud and … Tags: CAC40 Sectors: | 2183 | 1587 | 500 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 1746 | 1554 | 121 |
Chemistry